Davis, Stacy
Edwards, Teresa
Norcross, Lindsey
Fehnel, Sheri
Beaudet, Amélie
Eckart, Marie
Fastenau, John
Funding for this research was provided by:
Janssen Pharmaceuticals, Inc. (Not applicable)
Actelion Pharmaceuticals Ltd (Not applicable)
Article History
Received: 2 August 2023
Accepted: 7 December 2023
First Online: 18 December 2023
Declarations
:
: The present study was reviewed and determined exempt by RTI International’s institutional review board. Interview participants provided informed consent.
: In accordance with the informed-consent agreement, this publication includes no information that could personally identify participants.
: SD is an employee of Janssen Pharmaceuticals, Inc. At the time of this research, JF was an employee of Janssen. AB is an employee of Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson. At the time of this research, ME was an employee of Actelion. TE, LN, and SF are employees of RTI Health Solutions, which received funding from Janssen for conducting this research.